发明名称 Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis
摘要 A lipoprotein lipase (LPL) protein for treating and/or preventing HTG and its associated diseases, including but not limited to acute pancreatitis (AP), and in particular, acute pancreatitis secondary to or exacerbated by hypertriglyceridemia, and hypertriglyceridemia and its associated diseases in general, including cardiovascular and metabolic diseases, endocrine disorders, and fat embolism syndrome.
申请公布号 US9597376(B2) 申请公布日期 2017.03.21
申请号 US201514830481 申请日期 2015.08.19
申请人 Shire Human Genetic Therapies, Inc. 发明人 Francone Omar L.;Guey Lin;Holmes Kevin;Tangarone Bruce;Traylor Matthew;von Krusenstiern Lenore;Dowie Tracy;Low Lieh Yoon;Zhang Bohong;Meiyappan Muthuraman;Norton Angela;Strack-Logue Bettina;Lundberg Dianna;Concino Michael F.
分类号 A61K38/46 主分类号 A61K38/46
代理机构 Proskauer Rose LLP 代理人 Chen Fangli;Proskauer Rose LLP
主权项 1. A method of treating hypertriglyceridemia comprising administering a LPL polypeptide to a subject in need of treatment, wherein the LPL polypeptide comprises or consists of the amino acid of SEQ ID NO: 2.
地址 Lexington MA US